Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system

Carolyn Nicolson(National Institute for Biological Standards and Control), James S. Robertson(Brookhaven National Laboratory), John Wood(Women's and Children's Hospital), Diane Major(National Institute for Biological Standards and Control)
Vaccine
December 16, 2004
10.1016/j.vaccine.2004.08.054
Cited by 156

Related Papers

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
|Vaccine|2009|140
Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron 10
|Cancer|1955|116
The development of vaccine viruses against pandemic A(H1N1) influenza
|Vaccine|2011|109